ArticleJournal of clinical medicine2026
Review of Haematological Toxicities in Well-Differentiated Neuroendocrine Tumours: A Case Report and Comprehensive Review of the Literature.
David Gomez, Ramón Salazar, Paula Jiménez Fonseca, Ana Custodio, Beatriz Antón, Amaya Sadaba, Marta Benavent, Ana Elsa Huerta, Barbara Silvia Martinez, Itziar Gomez and 3 more
Abstract readCase Reports
In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
David GomezDepartment of Medical Oncology, Hospital Universitario de Navarra (HUN)-IdiSNA, Calle de Irunlarrea, 3, 31008 Pamplona-Iruña, Spain.ORCID 0000-0002-7265-0251 Ramón SalazarMedical Oncology Department, Oncobell Program IDIBELL Institut Català D'Oncologia (ICO) Duran I Reynals Hospital, Clinical Sciences Department, Bellvitge Campus, University of Barcelona, Centro de Investigación Biomédica en Red de Cáncer, 08007 Barcelona, Spain.ORCID 0000-0001-9419-6232 Paula Jiménez FonsecaDepartment of Medical Oncology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.ORCID 0000-0003-4592-3813 Ana CustodioDepartment of Medical Oncology, Hospital Universitario La Paz, 28046 Madrid, Spain.
Beatriz AntónDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.ORCID 0000-0001-9237-8614 Amaya SadabaDepartment of Medical Oncology, Hospital Universitario de Navarra (HUN)-IdiSNA, Calle de Irunlarrea, 3, 31008 Pamplona-Iruña, Spain.
Marta BenaventDepartment of Medical Oncology, Hospital Universitario Virgen Del Rocío, 41013 Sevilla, Spain.ORCID 0000-0003-1268-4588 Ana Elsa HuertaTranslational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.
Barbara Silvia MartinezDepartment of Nurse, Hospital Universitario de Araba, 01009 Vitoria, Spain.
Itziar GomezDepartment of Nurse, Hospital Universitario de Araba, 01009 Vitoria, Spain.
Nieves Martínez LagoMedical Oncology Department, Santiago de Compostela University Clinical Hospital (CHUS) and Health Research, Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.ORCID 0000-0002-0408-6871 Jorge HernandoDepartment of Medical Oncology, Hospital Universitario Vall D'Hebron, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.
Ruth VeraDepartment of Medical Oncology, Hospital Universitario de Navarra (HUN)-IdiSNA, Calle de Irunlarrea, 3, 31008 Pamplona-Iruña, Spain.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
“adverse effects” [Subheading]“antineoplastic agents” [Mesh]“gastro-enteropancreatic neuroendocrine tumor” [Supplementary Concept]“neuroendocrine tumors” [Mesh]peptide receptor radionuclide therapy“streptozocin” [Mesh]“thrombocytopenia” [Mesh]
Identifiers
PMID42355796
PMCPMC13302579
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390